Investor Relations

Investor Relations

We are a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart

Events & Presentations

Date Title
10/25/18 BTIG Biotech Conference
10/02/18 at
3:30 PM EDT
Ladenburg Thalmann 2018 Healthcare Conference
 
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet